Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 17 Rectal Neoplasms 9 Triple Negative Breast Neoplasms 7 Stomach Neoplasms 7 Colorectal Neoplasms 6 Adenocarcinoma 6 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Adenocarcinoma Of Esophagus 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Pancreatic Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasms 3 Esophageal Squamous Cell Carcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Advanced Solid Tumour 2 Solid Tumors 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Locally Advanced Gastric Cancer 1 HIV Infections 1 HER2-positive Gastric Cancer 1 HER2-positive Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumor × Capecitabine × 30 days × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡